Ayalon Insurance Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MSR
PR
SO
WT
AAS
WAM
RFM
NHFG
RAM
Ayalon Insurance Company's XBI Position: Q2 2026 in Review
Ayalon Insurance Company opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 55,600 shares worth $8.8M. The stake represents 1.08% of the portfolio and ranks #24 among its holdings. This is a return to the name: Ayalon Insurance Company previously reported a position in XBI as recently as Q2 2022.
Ayalon Insurance Company first reported a position in XBI in Q4 2017 and has held it in 19 quarters since. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Ayalon Insurance Company held 55,600 shares of State Street SPDR S&P Biotech ETF worth $8.8M as of Q2 2026.
- State Street SPDR S&P Biotech ETF was a new Ayalon Insurance Company position in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 1.08% of Ayalon Insurance Company's portfolio in Q2 2026, its #24 holding.
- Ayalon Insurance Company first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 19 quarters since.
- 393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Ayalon Insurance Company's 13F filing for Q2 2026, filed 13 Jul 2026.